Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Living with ringing in your ears? Updated guideline supports a personalized, evidence-based approach to tinnitus (opens in a new tab)

medicalxpress.com · 2026-10-12

Short answerEvidenceSource

Short answer

Mostly supported

Mostly supported.

One claim goes further than the study.

  • 4 supported
  • 1 overstated

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1

The story

Living with ringing in your ears? Updated guideline supports a personalized, evidence-based approach to tinnitus

medicalxpress.com · 2026-10-12

The story’s checkable claims.

Read the original story (opens in a new tab)
2

NewsLink checks it

Mostly supported

One claim overstates the study. Four of five check out.

  • 4 supported
  • 1 overstated
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5OverstatedThe guideline says every patient with tinnitus should receive a comprehensive hearing evaluation and clinicians should ask directly about emotional distress and thoughts of self-harm.View evidenceHide evidence

Why this verdict

The paper supports comprehensive audiological evaluation and inquiry about self-harm risk, but the story frames this as applying to 'every patient with tinnitus' and adds direct screening for emotional distress. The profile's scope is adults with persistent, bothersome tinnitus, and the abstract-level KAS evidence specifically mentions self-harm risk rather than a broader emotional-distress screening requirement.

1

Study evidence

Clinicians should distinguish patients with bothersome tinnitus from those with non‑bothersome tinnitus (KAS 2).

“Clinical Practice Guideline: Tinnitus Update”
Claim 2 of 5SupportedThe American Academy of Otolaryngology Head and Neck Surgery Foundation has published an updated Clinical Practice Guideline for tinnitus.View evidenceHide evidence

Why this verdict

The paper profile identifies the document as 'Clinical Practice Guideline: Tinnitus Update' from AAO-HNSF and states that its purpose is to provide updated evidence-based recommendations for tinnitus management.

1

Study evidence

Clinicians should distinguish patients with bothersome tinnitus from those with non‑bothersome tinnitus (KAS 2).

“Clinical Practice Guideline: Tinnitus Update”
Claim 3 of 5SupportedThe updated guideline focuses on adults with persistent and bothersome tinnitus, defined here as lasting six months or longer and affecting quality of life.View evidenceHide evidence

As statedsix months or longer

Why this verdict

The profile states that the guideline targets adults with persistent, bothersome tinnitus, with persistent defined as at least 6 months and bothersome tinnitus affecting quality of life.

1

Study evidence

Clinicians should distinguish patients with bothersome tinnitus from those with non‑bothersome tinnitus (KAS 2).

“Clinical Practice Guideline: Tinnitus Update”
Claim 4 of 5SupportedThe guideline says cognitive behavioral therapy, hearing aids, and sound enrichment can help some people manage tinnitus, but there is no single approach that works for everyone.View evidenceHide evidence

Why this verdict

The profile supports recommending CBT for persistent, bothersome tinnitus, hearing-aid evaluation when hearing difficulties coexist, and sound enrichment as an option. The story's phrasing that these can help some people and that management should be individualized is consistent with the guideline's differing recommendation strengths and patient-context caveats.

1

Study evidence

Clinicians should distinguish patients with bothersome tinnitus from those with non‑bothersome tinnitus (KAS 2).

“Clinical Practice Guideline: Tinnitus Update”
Claim 5 of 5SupportedThe guideline recommends against routinely using medications, dietary supplements, or repetitive transcranial magnetic stimulation to treat tinnitus.View evidenceHide evidence

Why this verdict

The profile reports recommendations against routine use of specified medication classes for primary tinnitus treatment, dietary supplements for tinnitus, and rTMS. The story's wording is broadly consistent, though the profile is more specific about which medications and that the recommendation concerns primary treatment of tinnitus.

1

Study evidence

Clinicians should distinguish patients with bothersome tinnitus from those with non‑bothersome tinnitus (KAS 2).

“Clinical Practice Guideline: Tinnitus Update”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The guideline also includes targeted history and physical examination, distinguishing bothersome from non-bothersome tinnitus, patient education, cochlear implant referral when audiologic criteria are met, outcome assessment, somatosensory-feature inquiry, and bimodal neuromodulation as an option.

    These additional Key Action Statements are present in the profile but are not reflected in the supplied story summary or claims.

    From Clinical practice guideline (AAO‑HNSF development manual)

  • Medication recommendations against routine use are limited to primary treatment of tinnitus; such medications may still be used for appropriate comorbid conditions.

    The story says medications are not routinely recommended to treat tinnitus but does not include the profile's caveat that relevant drugs may be appropriate for comorbid conditions.

    From Clinical practice guideline (AAO‑HNSF development manual)

7 things the story did carry across
  • The paper is an AAO-HNSF updated clinical practice guideline providing evidence-based Key Action Statements for tinnitus evaluation and management.
  • The guideline scope is adults with persistent, bothersome tinnitus, including persistence of at least 6 months and impact on quality of life.
  • The guideline recommends comprehensive audiological evaluation for patients with tinnitus within the guideline scope.
  • The guideline includes risk assessment for self-harm in patients with bothersome tinnitus.
  • The guideline advises selective, not routine, neuroradiologic imaging unless concerning features are present.
  • The guideline recommends CBT, hearing-aid evaluation when hearing difficulties coexist, and sound enrichment as an option for persistent, bothersome tinnitus.
  • The guideline recommends against routine use of specified medications for primary tinnitus treatment, dietary supplements for tinnitus, and rTMS.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

1

Evidence read

study summary

Lead result

other

1Lead resultotherProvide updated, evidence-based clinical practice recommendations (Key Action Statements) for the evaluation and management of persistent, bothersome tinnitus in adults.Clinical practice guideline (AAO‑HNSF development manual)Expand

In plain English

AAO‑HNSF clinical practice guideline update presenting evidence‑based Key Action Statements (KAS 1–15) for evaluation and management of adults (≥18 years) with persistent (≥6 months), bothersome tinnitus. The guideline, developed using the AAO‑HNSF Clinical Practice Guideline Development Manual (3rd ed.), issues strong recommendations, recommendations, recommendations against, and options covering initial evaluation (history/physical, audiology), risk assessment (including self‑harm), selective use of imaging, and treatment approaches (recommend CBT, hearing‑aid and cochlear implant pathways when indicated; recommend against routine use of antidepressants, anticonvulsants, anxiolytics, intratympanic medications, dietary supplements, and rTMS; offer options such as sound enrichment, inquiry about somatosensory features, and bimodal neuromodulation).

Key findings

  • Clinicians should distinguish patients with bothersome tinnitus from those with non‑bothersome tinnitus (KAS 2).
  • Clinicians should inquire about risks for self‑harm in patients with bothersome tinnitus (KAS 3).
“Clinical Practice Guideline: Tinnitus Update”
What this piece can’t prove
  • Guideline scope limited to adults with persistent, bothersome tinnitus (target population explicitly defined).

2 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Crossref, Europe PMC · 28 candidate papers

And 22 more candidates considered.